FIELD: biotechnology.
SUBSTANCE: invention relates to immunogenic mutants of protein F of respiratory syncytial virus (RSV), and can be used in medicine.
EFFECT: mutants of protein F according to the present invention enable to obtain effective RSV vaccines.
27 cl, 14 dwg, 28 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
F RSV PROTEIN MUTANTS | 2016 |
|
RU2788403C2 |
RSV F MUTANT PROTEIN AND ITS APPLICATION | 2020 |
|
RU2807742C1 |
ANTIGENIC POLYPEPTIDES BASED ON THE RESPIRATORY SYNCYTIAL VIRUS SEQUENCE | 2019 |
|
RU2807992C2 |
ENGINEERED MULTI-SPECIFIC ANTIBODIES AND OTHER MULTIMERIC PROTEINS WITH ASYMMETRIC MUTATIONS IN THE CH2-CH3 REGION | 2018 |
|
RU2804031C2 |
RSV PROTEINS IN PRE-CONFLUENCE CONFORMATION AND USE THEREOF | 2014 |
|
RU2761631C2 |
STABILIZED F RSV PROTEINS AND THEIR USE | 2019 |
|
RU2795459C2 |
MULTIVALENT PD-L1-BINDING COMPOUNDS FOR TREATING MALIGNANT NEOPLASMS | 2020 |
|
RU2816646C2 |
EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
FUSED PROTEIN CONSTRUCTS FOR COMPLEMENT-RELATED DISEASE | 2019 |
|
RU2824402C2 |
SUBUNIT VACCINE FOR TREATING OR PREVENTING RESPIRATORY TRACT INFECTION | 2020 |
|
RU2811991C2 |
Authors
Dates
2020-06-08—Published
2016-12-09—Filed